Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2025-12-25 @ 12:12 PM
NCT ID: NCT00852761
Description: None
Frequency Threshold: 5
Time Frame: Baseline through Day 15.
Study: NCT00852761
Study Brief: A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Olux-E Foam Olux-E (clobetasol propionate 0.05%) foam None None 0 17 0 17 View
Clobex Lotion Clobex (clobetasol propionate 0.05%) lotion. None None 0 17 2 17 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nausea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA, Version 11.1 View
Dizziness NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA, Version 11.1 View
Hpertension NON_SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA, Version 11.1 View